ArticleTranslational andrology and urology2026
Utilizing intraoperative frozen section examination (IFSE) for diagnosis and treatment in a high-clinical-suspicion prostate cancer (PCa) cohort based on
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The diagnosis of prostate cancer (PCa) relies predominantly on definitive histopathological assessment. Although intraoperative frozen section examination (IFSE) is infrequently employed in prostate biopsy procedures, its integration with radical resection has been more widely adopted in other solid tumor settings. This study aims to evaluate the feasibility of an integrated diagnostic and therapeutic strategy-guided by IFSE-for patients with clinically high-risk or radiologically suspicious PCa. Methods: Patients with highly suspected PCa, characterized by Results: A total of 56 patients were enrolled in the study. The median age was 67.4 years, with a median prostate-specific antigen (PSA) level of 22.2 ng/mL. Among the patients, 12 had a PI-RADS score of 4, and 44 had a score of 5. The median SUVmax value was 14.3. Twenty-two patients exhibited abnormal digital rectal examination (DRE) findings. IFSE confirmed PCa in all 56 patients (100%). All patients successfully underwent both targeted prostate biopsy and RP in a single surgical procedure. Postoperative pathology revealed positive surgical margins in 19 patients and seminal vesicle invasion in 4 patients. Tumor stages were distributed as follows: T2a (n=8), T2b (n=23), T2c (n=15), T3a (n=6), and T3b (n=4). Urinary continence was fully restored within 3 months postoperatively. Twenty-seven patients received adjuvant therapy. No biochemical recurrence was observed during follow-up. Conclusions: For patients with highly suspicious PCa on imaging, the integrated diagnostic and therapeutic approach utilizing IFSE is feasible. This method serves as an effective complement to the traditional PCa management model. However, the appropriate standards and safety profile for this procedure remain to be fully established.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.